Disorders of purines and pyrimidines

Assmann, 1998, Presumptive ureidopropionase deficiency as a new defect in pyrimidine catabolism found with in vitro H-NMR spectroscopy, J Inherit Metab Dis, 21, 1 Bakkeren, 1984, Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency, Clin Chim Acta, 140, 247, 10.1016/0009-8981(84)90206-7 Becker, 1987, Mechanism of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetase, J Biol Chem, 262, 5596, 10.1016/S0021-9258(18)45615-3 Becker, 1988, Superactivity of phosphoribosylpyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate, Biochim Biophys Acta, 882, 168, 10.1016/0304-4165(86)90151-0 Becker, 1988, Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorial deafness, Am J Med, 85, 383, 10.1016/0002-9343(88)90591-8 Becker, 1995, The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity, J Clin Invest, 96, 2133, 10.1172/JCI118267 Berger, 1984, Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria, An inborn error of pyrimidine metabolism. Clin Chim Acta, 141, 227, 10.1016/0009-8981(84)90014-7 Blau, 1996, Tetrahydrobiopterin loading test in xanthine dehydrogenase and molybdenum cofactor deficiencies, Biochem Mol Med, 58, 199, 10.1006/bmme.1996.0049 Bzowska, 2000, Purine nucleoside phosphorylases: properties, functions, and clinical aspects, Pharmacol Ther, 88, 349, 10.1016/S0163-7258(00)00097-8 Calabrese, 1990, Precocious familial gout with reduced fractional urate clearance and normal purine enzymes, Q J Med, 75, 441 Camici, 2010, Pediatric neurological syndromes and inborn errors of purine metabolism, Neurochem Int, 56, 367, 10.1016/j.neuint.2009.12.003 Chalmers, 1969, Microscopic studies on crystals in skeletal muscle from two cases of xanthinuria, J Pathol, 99, 45, 10.1002/path.1710990107 Chou, 2007, Gene therapy for type I glycogen storage diseases, Curr Gene Ther, 7, 79, 10.2174/156652307780363152 Chou, 2002, Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex, Curr Mol Med, 2, 121, 10.2174/1566524024605798 Crifò, 2005, Inhibition of defective adenylsuccinate lyase by HNE: a neurological disease that may be affected by oxidative stress, Biofactors, 24, 131, 10.1002/biof.5520240115 Dalal, 2001, Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient, Clin Genet, 59, 430, 10.1034/j.1399-0004.2001.590608.x De Brouwer, 2007, Arts syndrome is caused by loss-of-function mutations in PRPS1, Am J Hum Genet, 81, 507, 10.1086/520706 De Volder, 1988, Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography, Pediatr Res, 24, 238, 10.1203/00006450-198808000-00020 Endres, 1988, Report on a new patient with combined deficiencies of sulphite oxidase and xanthine dehydrogenase due to molybdenum cofactor deficiency, Eur J Pediatr, 148, 246, 10.1007/BF00441412 Eriksson, 2008, Molecular mechanism of mitochondrial DNA depletion diseases caused by deficiencies in enzymes in purine and pyrimidine metabolism, Nucleosides Nucleotides Nucleic Acids, 27, 800, 10.1080/15257770802146197 Eriksson, 2002, Structure and function of cellular deoxyribonucleoside kinases, Cell Mol Life Sci, 59, 1327, 10.1007/s00018-002-8511-x Fishbein, 1978, Myoadenylate deaminase deficiency: a new disease of muscle, Science, 200, 545, 10.1126/science.644316 Fox, 1972, Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition, J Biol Chem, 247, 2126, 10.1016/S0021-9258(19)45500-2 Giblett, 1972, Adenosine deaminase deficiency in two patients with severely impaired cellular immunity, Lancet, 2, 1067, 10.1016/S0140-6736(72)92345-8 Giblett, 1975, Nucleoside phosphorylase deficiency in a child with severely defective T cell immunity and normal B cell immunity, Lancet, 1, 1010, 10.1016/S0140-6736(75)91950-9 Hamajima, 1998, Dihydropyrimidinase deficiency: structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene, Am J Hum Genet, 63, 717, 10.1086/302022 Hirschhorn, 1993, Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency, Pediatr Res, 33, 35, 10.1203/00006450-199333011-00008 Hirschhorn, 1980, Amelioration of neurological abnormalities after enzyme replacement of adenosine deaminase deficieincy, N Engl J Med, 303, 377, 10.1056/NEJM198008143030706 Huguley, 1959, Refractory megaloblastic anaemia associated with excretion of orotic acid, Blood, 14, 615, 10.1182/blood.V14.6.615.615 Ichida, 1997, Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria, J Clin Invest, 99, 2391, 10.1172/JCI119421 Janecke, 2001, Molecular genetics of type 1 glycogen storage disease, Mol Genet Metab, 73, 117, 10.1006/mgme.2001.3179 Jinnah, 2006, Delineation of the motor disorder of Lesch–Nyhan disease, Brain, 129, 1201, 10.1093/brain/awl056 Johansson, 1996, Localization of the human deoxyguanosine kinase gene (DGUOK) to chromosome 2p13, Genomics, 38, 450, 10.1006/geno.1996.0654 Johnson, 2003, Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulphite oxidase deficiency, Prenat Diagn, 23, 6, 10.1002/pd.505 Kelley, 1969, Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout, Ann Intern Med, 70, 155, 10.7326/0003-4819-70-1-155 Kim, 2007, Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic atrophy (CMTX5), Am J Hum Genet, 81, 552, 10.1086/519529 Krishnan, 2008, Long-term cardiovascular mortality among middle-aged men with gout, Arch Intern Med, 168, 1104, 10.1001/archinte.168.10.1104 Labarthe, 2005, Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency, J Hepatol, 43, 333, 10.1016/j.jhep.2005.03.023 Laikind, 1986, Detection of 5′-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton–Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity, Analyt Biochem, 156, 81, 10.1016/0003-2697(86)90158-2 Lesch, 1964, A familial disorder of uric acid metabolism and central nervous system function, Am J Med, 36, 561, 10.1016/0002-9343(64)90104-4 Mandel, 2001, The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA, Nat Genet, 29, 337, 10.1038/ng746 Marie, 2004, AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC, Am J Hum Genet, 74, 1276, 10.1086/421475 Markert, 1994, Molecular basis of adenosine deaminase deficiency, Immunodeficiency, 5, 141 Meinsma, 1995, Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uraciluria, DNA Cell Biol, 14, 1, 10.1089/dna.1995.14.1 Morisaki, 1992, Molecular basis of AMP deaminase deficiency in skeletal muscle, Proc Natl Acad Sci, 89, 6457, 10.1073/pnas.89.14.6457 Nguyen, 2012, Lesch–Nyhan syndrome: mRNA expression of HPRT in patients with enzyme proven deficiency of HPRT and normal HPRT coding region of the DNA, Mol Genet Metab, 106, 498, 10.1016/j.ymgme.2012.06.003 Nofech-Mozes, 2007, Neurologic abnormalities in patients with adenosine deaminase deficiency, Pediatr Neurol, 37, 218, 10.1016/j.pediatrneurol.2007.03.011 Nyhan, 2005, Disorders of purine and pyrimidine metabolism, Mol Genet Metab, 86, 25, 10.1016/j.ymgme.2005.07.027 Page, 1981, Hypoxanthine guanine phosphoribosyl transferase variants: correlation of clinical phenotype with enzyme activity, J Inherit Metab Dis, 4, 203, 10.1007/BF02263652 Page, 1997, Developmental disorder associated with increased cellular nucleotidase activity, Proc Natl Acad Sci U S A, 94, 11601, 10.1073/pnas.94.21.11601 Pesi, 2000, Cystolic 5′-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients, Neuroreport, 11, 1827, 10.1097/00001756-200006260-00006 Rogers, 2001, Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency, J Pediatr, 139, 44, 10.1067/mpd.2001.115023 Salerno, 1997, Failure of muscle energy metabolism in a patient with adenylosuccinase deficiency An in vivo study by phosphorus NMR spectroscopy, Biochim Biophys Acta, 1360, 271, 10.1016/S0925-4439(97)00010-0 Salerno, 1999, Effect of D-ribose on purine synthesis and neurological symptoms in a patient with adenylosuccinase deficiency, Biochim Biophys Acta, 1453, 135, 10.1016/S0925-4439(98)00093-3 Salgueiro, 2004, Mutations in exon 14 of dihydropyridimine dehydrogenase and 5′-fluorouracil toxicity in Portuguese colorectal cancer patients, Genet Med, 6, 102, 10.1097/01.GIM.0000118061.66602.A5 Salviati, 2002, Mitochondrial DNA depletion and dGK gene mutations, Ann Neurol, 52, 311, 10.1002/ana.10284 Schlesinger, 2010, Diagnosing and treating gout: a review to aid primary care physicians, Postgrad Med, 122, 157, 10.3810/pgm.2010.03.2133 Sidi, 1985, Z-nucleotide accumulation in erythrocytes from Lesch–Nyhan patients, J Clin Invest, 76, 2416, 10.1172/JCI112255 Smith, 1961, Pyrimidine metabolism in man IV The enzymatic defect of orotic aciduria, J Clin Invest, 40, 656, 10.1172/JCI104298 Spiegel, 2006, Adenylosuccinate lyase deficiency, Mol Genet Metab, 89, 19, 10.1016/j.ymgme.2006.04.018 Suchi, 1997, Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families, Am J Hum Genet, 60, 525 Sumi, 1997, Pyrimidine metabolism in hereditary orotic aciduria, J Inherit Metab Dis, 20, 104, 10.1023/A:1005330127995 Trifilo, 2000, NAPDD patients exhibit altered electrophoretic mobility of cytosolic 5′nucleotidase, Adv Exp Med Biol, 486, 87, 10.1007/0-306-46843-3_17 Turner, 2003, UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy, J Clin Endocrinol Metab, 88, 1398, 10.1210/jc.2002-021973 Van Gennip, 1997, Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects, J Inherit Metab Dis, 20, 203, 10.1023/A:1005356806329 van Kuilenburg, 2004, B-ureipropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities, Hum Mol Genet, 13, 2793, 10.1093/hmg/ddh303 Wada, 1974, Hypouricemic mentally retarded infant with a defect of 5-phosphoribosyl-1-pyrophosphate synthetase of erythrociytes, Tohoku J Exp Med, 113, 149, 10.1620/tjem.113.149 Wadman, 1983, Absence of hepatic molybdenum cofactor: an inborn error of metabolism leading to a combined deficiency of suphite oxidase and xanthine dehydrogenase, J Inherit Metab Dis, 6, 78, 10.1007/BF01811328 Wong, 1996, Dopamine transporters are markedly reduced in Lesch–Nyhan disease in vivo, Proc Natl Acad Sci U S A, 93, 5539, 10.1073/pnas.93.11.5539